What MagVenture does

MagVenture A/S, founded in 1992 and headquartered in Farum, Denmark, is a privately-held medical device company that designs, manufactures, and globally distributes Transcranial Magnetic Stimulation (TMS) systems under the MagPro product family. The company's core technology delivers non-invasive electromagnetic pulses to targeted brain regions for the treatment of major depressive disorder (MDD), obsessive-compulsive disorder (OCD), psychoactive substance use disorders (PSUD/addiction), and comorbid anxiety, plus diagnostic and research applications based on motor evoked potentials (MEP). The hardware portfolio spans entry-level stimulators (MagPro R20), standard/legacy clinical units (MagPro R30), enhanced systems with the MagOption (biphasic and monophasic waveforms, paired-pulses), ultra-high-performance research units (MagPro R30 Accelerated+, MagPro XP Orange Edition at 250 pps), a broad range of circular and butterfly coils (C-100, C-B70, MCF-B70, Cool-B70), and accessories including the patented Flow Arm, treatment chairs, and high-performance liquid cooling systems. Pre-configured therapy packages bundle stimulator, coil, navigation, and cooling for specific clinical and research use cases.

The business model is anchored on one-time capital equipment sales with no recurring pay-per-use or subscription fees, supplemented by professional services revenue from clinical training programs (notably the MagVenture Accelerator Training Program at the Farum HQ), distributor enablement workshops, and ongoing technical/clinical support through managed service agreements. Go-to-market combines wholly-owned sales subsidiaries in five priority markets (USA, Germany, UK, Brazil, China) with an exclusive distributor network spanning 60–70+ countries, reaching psychiatrists, mental health clinics, neurologists, pain therapists, and neuroscience/clinical research institutions. Distribution is supported by a multi-channel marketing engine that includes direct field sales, industry conferences (APA, DGHP, CTMSS), a Knowledge Hub of clinical evidence, educational webinars, e-books, and ROI-based package builders. The company invests in research collaborations with leading academic centers (Stanford, CAMH, Harvard Medical School, MUSC, CHUM, Inselspital, HUG) and holds strategic technology partnerships with Localite (neuronavigation), Axilum Robotics (robotic coil positioning), Brain Products (EEG), and Sync2Brain (closed-loop TMS), while operating under ISO 13485:2016, MDD/MDR, and MDSAP quality and regulatory frameworks and holding CE marks across four indications plus an FDA clearance for the MeRT PTSD protocol delivered on its systems.

Name

MagVenture

Legal name

MagVenture A/S

Website

https://magventure.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Short description

MagVenture is a privately-held Danish medical device manufacturer that designs and globally distributes non-invasive Transcranial Magnetic Stimulation (TMS) systems for treating depression, OCD, and addiction, plus diagnostic and neuroscience research applications, via wholly-owned subsidiaries and a 60+ country distributor network.

Ownership category

akta.pro rank

Product category

Transcranial Magnetic Stimulation (TMS) Systems

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL)

Keywords

• Transcranial magnetic stimulation
• Neuromodulation systems
• Magnetic stimulation devices
• TMS therapy systems
• Brain stimulation equipment

Headquarters

HQ city

Alpharetta

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. TMS Hardware Sales: One-time capital sale of TMS systems including stimulators, coils, and accessories. No pay-per-use or recurring fees - single investment covers system usage for product lifetime.
2. Training and Education Services: Technical training programs for distributors, clinical training for practitioners, and educational workshops including the Accelerator Training Program at HQ in Denmark.
3. Clinical Support Services: Ongoing service and support through global distributor network, including technical support, repairs, and warranty services.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

MagVenture designs, manufactures, and globally distributes non-invasive Transcranial Magnetic Stimulation (TMS) systems — the MagPro family of stimulators (MagPro Compact, MagPro R20, MagPro R30, MagPro R30 with MagOption, MagPro XP Orange Edition) — together with a portfolio of stimulation coils, positioning and cooling accessories, and pre-configured therapy/research packages. Offerings are sold as one-time capital equipment with no pay-per-use fees, CE-marked for treatment of Major Depressive Disorder, OCD, addiction, and comorbid anxiety, and widely used by psychiatrists, neuroscience researchers, neurologists, and pain therapists.

Product overview

MagVenture is a leading provider of non-invasive Transcranial Magnetic Stimulation (TMS) systems for brain stimulation, offering a comprehensive portfolio of stimulators, coils, accessories, and pre-configured therapy packages. The product lineup centers on the MagPro stimulator family including MagPro Compact (diagnostic), MagPro R20 (compact therapy), MagPro R30 (standard/high-performance therapy), MagPro R30 with MagOption (enhanced protocols), and MagPro XP Orange Edition (ultra-high-performance 250 pps). Coil options include circular (C-100), butterfly (C-B70, MCF-B70, Cool-B70), and specialized coils for multi-site stimulation and animal research. Accessories include positioning arms (Flow Arm, Super Flex Arm), patient support (Treatment Chair, Vacuum Pillow), cooling systems, and navigation/robotic integrations. Pre-configured packages combine stimulators, coils, and accessories for specific use cases: R20 Therapy Package (standard rTMS), R30 packages (standard therapy), R30 with Flow Arm packages (enhanced ergonomics), and R30 Accelerated packages with Localite neuronavigation (precision Theta Burst protocols). Integration partnerships with Localite (neuronavigation), Axilum Robotics (robotic positioning), Brain Products (EEG), and Sync2Brain enable advanced research applications including TMS/fMRI, closed-loop TMS, and robotic TMS.

Differentiator

Problem solved

Functional benefit

Brands

• MagVenture TMS Therapy: Clinical TMS systems for treatment of depression, OCD, addiction, and comorbid anxiety.
• MagPro
• MagVenture Go
• MagVenture Accelerator Training Program

Products and services

• MagPro Compact Legacy TMS stimulator for electro-physiological assessment based on motor evoked potential (MEP), designed for diagnostic use in combination with EMG equipment with TTL trigger compatibility (up to 5 Hz/pps using external trigger). Targets neurologists and clinical neurophysiologists.
• MagPro R20 Compact magnetic stimulator for electro-physiological assessment and therapeutic rTMS, supporting standard 10 Hz or 15 Hz protocols up to 100 Hz/pps with biphasic waveform. Designed for clinics running a limited number of TMS sessions per day.
• MagPro R30 High-performance TMS stimulator for clinical use and research, supporting repetitive transcranial magnetic stimulation with complex protocols up to 20,000 pulses per session, theta burst option with 30, 60, and 80 pps, biphasic waveform, and storage of multiple protocols. Up to 80 Hz/pps.
• MagPro R30 with MagOption Enhanced MagPro R30 providing biphasic and monophasic pulse waveforms, paired-pulse/twin-pulse capability, complex pulse firing patterns, high-frequency stimulation up to 30 Hz, and diagnostic capabilities.
• MagPro XP Orange Edition Ultra-high-performance TMS device delivering 250 pulses per second, over twice the power of standard stimulators. First TMS device to bridge electrophysiological memory models and TMS using brain frequency. Features integrated coil cooling and fully encased console design for easy lab transport. Supports ultra-focal stimulation without overheating.
• C-100 Coil Circular TMS coil without cooling, suitable for diagnostic use. Equipped with power control and trigger button integrated in the handle for ease of operation.
• C-B70 Coil Butterfly-shaped TMS coil without cooling, suitable for focused stimulations. Enables motor mapping even in difficult cases with the same magnetic field strength as the Cool-B70.
• MCF-B70 Coil Butterfly-shaped TMS coil with static cooling for focused protocols requiring a higher number of stimuli without external active cooling. Designed with a slightly bent surface for best contact with the skull.
• Cool-B70 Coil Butterfly-shaped TMS coil with active cooling for demanding protocols requiring a high number of stimuli. Electrically and magnetically comparable with MCF-B70, with built-in timer and counter.
• Flow Arm Patented arm designed to support easy placement of the TMS treatment coil, reducing operator strain for multiple daily sessions. Optimizes clinical workflow while maintaining accuracy and flexibility. Compatible with Treatment Chairs purchased after Q1 2017.
• Treatment Chair with Neckrest Treatment chair developed for TMS Therapy with wide adjustment options. Features adjustable height, seat angle, footrest, and backrest operated by remote control. Compatible with Flow Arm and Super Flex Arm.
• Super Flex Arm for Coils Flexible positioning arm with three joints for multi-directional coil placement. Available in long and short versions for trolley or treatment chair mounting.
• R20 Therapy Package Compact therapy system suitable for standard rTMS approved protocols. Includes MagPro R20, MCF-B70 coil, isolation transformer and trolley. Features friendly interface, multiple sessions per day capability, compact installation, up to 100 Hz/pps, and biphasic waveform. Suited for clinics starting their TMS practice.
• R30 with Flow Arm Package Standard therapy system suitable for most rTMS protocols including the patented Flow Arm. The MagPro R30 is the company's standard therapeutic stimulator in use in 70+ countries since 2003. Includes liquid cooling and biphasic waveform; up to 80 Hz/pps.
• R30 Standard Level Therapy Package Standard therapy system suitable for most rTMS protocols. Includes MagPro R30 stimulator, Super Flex Arm, and isolation transformer for versatile clinical use. Up to 80 Hz/pps, biphasic waveform, high-performance and versatile interface.
• R30 Package with Localite-Value Navigation Neuronavigated TMS research system with Localite-Value navigation suitable for refined rTMS protocols targeting individual treatment spots. Includes C-B70 coil, Flow Arm, NDI Vicra cam, high-performance cooling option. Supports classic and MRI neuronavigation, up to 80 Hz/pps, biphasic waveform.
• R30 Package with Localite-Premium Navigation Neuronavigated TMS research system with Localite-Premium navigation for high precision, featuring NDI Spectra camera for precise repeatability. Includes high-performance cooling, biphasic waveform, up to 80 Hz/pps, supports classic and MRI neuronavigation.
• R30 Accelerated Package with Localite-Value Navigation Neuronavigated TMS system powered by high-performance cooling for accelerated Theta Burst protocols. Includes Localite-Value navigation with NDI Vicra cam, classic and MRI neuronavigation, biphasic waveform, up to 80 Hz/pps.
• R30 Accelerated+ Package with Localite-Premium Navigation Top-tier neuronavigated TMS system with high-performance cooling for accelerated Theta Burst protocols. Includes Localite-Premium navigation with NDI Spectra cam, Flow Arm, Cool-B70 coil, Treatment Chair, and full accessory suite. Supports classic and MRI neuronavigation, biphasic waveform, up to 80 Hz/pps.
• Diagnostic Compact Legacy TMS system for electro-physiological assessment based on motor evoked potential (MEP). Compact installation designed to fit EMG setups, with C-100 circular coil, biphasic waveform, TTL trigger compatibility, and up to 5 Hz/pps using external trigger.
• MagVenture Go Mobile TMS solution designed to expand clinical care possibilities. Features flexibility and accessibility with compact, transport-ready design supporting seamless treatment continuity across multiple clinical sites. Targeted at providers and patients to reduce logistical barriers of fixed TMS installations.
• MagVenture Accelerator Training Program In-person 2-day educational experience at MagVenture HQ in Farum, Denmark for professionals working with TMS and neuromodulation. Covers scientific content, clinical discussions, and hands-on training with MagPro protocols and workflows. Designed for psychiatrists, researchers, and clinical staff adopting MagVenture systems.

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature9 records

Partnerships

13 partnerships are on record, tiered core and minor.

• LocalitecoreTechnology or IntegrationStrategic partnership for neuronavigation solutions. Localite provides TMS Navigator systems for planning stimulation areas, visualizing stimulation spots, and monitoring coil positions with complete reproducibility. Integration supports MR-less to MR-based neuronavigation with tracking up to 4 coils simultaneously.
• Axilum RoboticscoreTechnology or IntegrationPartnership for robotic TMS solutions providing head motion compensation. TMS-Cobot for clinical use and TMS-Robot for advanced research. Systems maintain coil position, orientation, and head contact during sessions, automatically adjusting for head movements.
• Brain ProductscoreTechnology or IntegrationPartnership for closed-loop TMS combining MagVenture stimulators with EEG technology. Enables real-time brain state-dependent TMS research by synchronizing stimulation with individual brain states within milliseconds of accuracy.
• Sync2braincoreTechnology or IntegrationPartnership for closed-loop TMS solutions. Combined with Brain Products EEG, enables detection of neurophysiological signals and TTL trigger generation for brain state-dependent stimulation protocols.
• Wave NeurosciencecoreTechnology or IntegrationFDA-cleared MeRT (Magnetic e-Resonance Therapy) system for PTSD treatment delivered on MagVenture technology. Combines quantitative EEG analysis with TMS for personalized treatment parameters. First FDA-cleared PTSD treatment using TMS technology.
• IPUminorImplementation/ SI/ Consulting PartnerSustainability consulting partnership for carbon reduction and product lifecycle assessments. IPU specializes in product development and sustainability with connections to Technical University of Denmark (DTU). Supporting MagVenture's commitment to NetZero by 2050.
• Stanford UniversitycoreStrategic or Co-development PartnerStanford Neuromodulation Therapy (SNT) research conducted using MagVenture systems. Landmark studies in accelerated theta burst stimulation treatment protocols.
• CAMH (Centre for Addiction and Mental Health)coreStrategic or Co-development PartnerLeading Canadian mental health institution conducting TMS research using MagVenture systems for depression and OCD treatment protocols.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerResearch institution conducting TMS studies using MagVenture R30 Accelerated packages for advanced neuromodulation protocols.
• MUSC (Medical University of South Carolina)minorStrategic or Co-development PartnerAcademic medical center collaborating on TMS research. Home to oldest medical school in South Carolina with integrated academic health sciences center.
• CHUM Research CentreminorStrategic or Co-development PartnerLargest biomedical science and healthcare research centre at Université de Montréal, collaborating on TMS clinical research.
• InselspitalminorStrategic or Co-development PartnerSwiss medical centre of competence and high technology with international appeal, conducting TMS research and innovation.
• HUG (Geneva University Hospitals)minorStrategic or Co-development PartnerSwiss university hospitals investing in clinical TMS research to develop treatments of tomorrow.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Yiruide (Shenzhen Yingri Technology): Chinese manufacturer of TMS systems and related neurotechnology products, including rTMS devices for depression. Competes with MagVenture in China and emerging APAC markets with cost-competitive offerings.
• Nexstim: Finland-based (publicly listed) developer of navigated TMS systems for depression and presurgical mapping. Competes with MagVenture's navigated/neuronavigated R30 packages in research and clinical applications.
• Brainsway: Israel-based (NASDAQ: BWAY) developer of Deep TMS systems with FDA clearance for MDD, OCD, and smoking addiction. Competes directly with MagVenture across the same clinical indications and customer segments, including accelerated protocols.
• Neurosoft: Russia-based manufacturer of TMS, EEG, and EMG equipment with global distribution. Competes with MagVenture in the clinical TMS and research-diagnostic segments at typically lower price points.
• Neuronetics: US-listed (STIM) developer of NeuroStar TMS systems for treatment-resistant depression and OCD. Most direct head-to-head competitor in the clinical rTMS market, with overlapping FDA-cleared indications and similar psychiatrist customer base.
• Magstim: UK-based manufacturer of TMS stimulators and coils (including the Rapid and Horizon ranges) for research and clinical use. Closest historical and product-line competitor to MagVenture in both neuroscience research and clinical therapy.

Broad incumbents

• Abbott (Neuromodulation): Through its St. Jude-acquired neuromodulation business, Abbott offers DBS and spinal cord stimulation systems. Relevant as a broad incumbent in the neuromodulation category that MagVenture's TMS technology partially overlaps.
• Medtronic (Neuromodulation): Global medical-device leader with deep brain stimulation (DBS) and other implantable neuromodulation franchises. Sets the broader neuromodulation standard and competes in adjacent psychiatric and neurological indications.
• Boston Scientific (Neuromodulation): Global medical-device company with VNS, SCS, and DBS neuromodulation products. Provides reference points for clinical adoption, reimbursement, and competitor positioning in the broader non-pharmacologic neurotherapy market.

Emerging players

• eNeura: Developer of single-pulse TMS devices (SpringTMS) cleared for migraine treatment and acute pain. Adjacent indication overlap with MagVenture's pain-therapist and neurology segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UClXO1ZPnR_x2DzSnDBgjJ4w
• LinkedInlinkedin.com/company/magventure
• Instagraminstagram.com/magventure.usa

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MagVenture